GAMCO Asset Management »

Cidara Therapeutics shares owned by GAMCO Asset Management

Quarter-by-quarter ownership of Cidara Therapeutics (CDTX) shares owned by GAMCO Asset Management from 13F filings

Historical chart of GAMCO Asset Management investment in Cidara Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cidara Therapeutics held by GAMCO Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cidara Therapeutics by GAMCO Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $2.8M 13k 220.89

More positions owned by GAMCO Asset Management

Mueller Industries Equity (MLI)
Gatx Corp Equity (GATX)
Crane Equity (CR)
Madison Square Garden Sports Equity (MSGS)
Herc Holdings Equity (HRI)
American Express Equity (AXP)
Bank Of New York Mellon Corp Equity (BK)
Sony Group Corp - Sp Depository Recei (SONY)
Ametek Equity (AME)
Textron Equity (TXT)
Watts Water Technologies-a Equity (WTS)
National Fuel Gas Equity (NFG)
Modine Manufacturing Equity (MOD)
Republic Services Equity (RSG)
Atlanta Braves Hlds A In-a Equity (BATRA)

View all positions for GAMCO Asset Management

Top funds holding Cidara Therapeutics

RA Capital Management
Vanguard Group
BlackRock
BVF
UBS Group
Darwin Global Management
Vivo Capital
State Street Corporation
Susquehanna International
FMR
Leucadia National Corporation
Paradigm Biocapital Advisors
Citadel Advisors
Henderson Group
Glazer Capital

View all funds holding Cidara Therapeutics